1. health and fitness

The global animal health active pharmaceutical ingredient (API) market is projected
to register an impressive expansion at 7.3% CAGR during the forecast period 2017 to
2025, according to a recent study by Persistence Market Research (PMR). PMR’s
study estimates the market to increase from revenues worth US$ 5,216.1 Mn in 2017
to reach US$ 9,162.2 Mn by 2025-end.
Asia Pacific (APAC) will continue to be the most lucrative region in the global
animal health active pharmaceutical ingredient market, with sales exhibiting the
second highest CAGR through 2025. APAC has remained one of the largest API
suppliers, at affordable costs. Governments across APAC have been making
investments and focusing on local manufacturing facilities of APIs. Favorable
policies offered by these governments have been shifting the focus of API
manufacturers in moving their production bases to APAC countries, such as India and
China. In addition, limited insurance or government intervention provides smooth
flow to market growth in these regions.
Request to view table of content @
https://www.persistencemarketresearch.com/toc/16972
However, animal health API products manufactured in APAC countries do not meet
regulatory standards, and there has been increasing concerns pertaining to the quality
of APIs, especially those produced in China and India. Western regulatory bodies are
becoming stricter in the inspection of APIs produced in these regions. Manufacturers
are further facing challenges in bridging the gap between the cost and quality of APIs.
These factors will inhibit growth of the market in APAC.
Europe will remain the second largest market for animal health active pharmaceutical
ingredients. Leading healthcare companies are located in the Europe, which in turn
has boosted requirement for veterinary APIs in the region. Consumption of veterinary
drugs in Europe has surged substantially over the past few years. Spain has been
witnessed to be the largest consumer of veterinary antimicrobial APIs in the EU. In
addition, rising improvements in the animal productivity has driven growth of the
animal health industry in this region. These incidences are expected to augment
growth of the animal health API market in Europe.
Request Sample Report @
https://www.persistencemarketresearch.com/samples/16972
However, the pharmaceutical industry in Europe has been concerned with potential
short-term impacts of REACH regulations. This is likely to result in decreased supply
of materials, or reagents, which are not preregistered by EU suppliers. In addition,
dynamic changes in Europe’s macro-economic environment, such as the Brexit, has
been impacting the intra-European trade and overall pharmaceutical sector. These
factors might curb growth of the animal health API market in Europe.
Antiparasitics will continue to be the largest adopted API in the market, followed by
anti-infectives. Sales of Antiparasitics are expected to register the fastest expansion,
to account for the largest revenues by 2025-end. In contrast, revenues from sales of
anesthetics and NSAIDs will remain comparatively lower than antiparasitics and antiinfectives.
Key market players profiled in PMR’s report include Glenmark Pharmaceutical
Limited., Zoetis, Inc., Eli Lilly & Co., Sanofi Winthrop Industrie (CEPiA), Indukern,
S.A., Ofichem BV, P&R S.p.A (Olon S.p.A), Lonza Group AG, Huvepharma AD,
Ourofino Saude Animal, Blanver Farmoquimica E Farmaceutica S.A., Zhejiang
Hisun Pharmaceutical Co., Ltd, Changzhou Yabang-Qh Pharmachem Co., Ltd.,
Shanghai Pharmtech Co., Ltd., Ningxia Tairui Pharmaceutical Co., Ltd., Shaanxi
Hanjiang Pharmaceutical Group Co., Ltd., Sequent Scientific Ltd., NGL Fine-Chem
Ltd., Omkar Speciality Chemicals Ltd., Excel Industries Ltd.
Buy Full Animal Health Active Pharmaceutical Ingredients Market Report @
https://www.persistencemarketresearch.com/checkout/16972
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research
model is a unique collaboration of data analytics and market research methodology to
help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a
multi-disciplinary approach. At PMR, we unite various data streams from multidimensional sources. By deploying real-time data collection, big data, and customer
experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: [email protected]
Web: http://www.persistencemarketresearch.com